Daniel Getts, Myeloid Therapeutics CEO

Myeloid Ther­a­peu­tics goes down un­der for new man­u­fac­tur­ing site, with $66M lo­cal in­vest­ment

Myeloid Ther­a­peu­tics is look­ing across the Pa­cif­ic to es­tab­lish a new man­u­fac­tur­ing site, and will be net­ting some ma­jor as­sis­tance from the lo­cal gov­ern­ment as …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.